Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![tenet_research Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::706191666219196420.png) TENET RESEARCH [@tenet_research](/creator/twitter/tenet_research) on x 452.8K followers
Created: 2025-07-08 20:01:52 UTC

$RYTM - Rhythm Pharmaceuticals To Announce Topline Results from Phase X Trial Evaluating Oral MC4R Agonist Bivamelagon in Acquired Hypothalamic Obesity


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942675525052387812/c:line.svg)

**Related Topics**
[$rytm](/topic/$rytm)

[Post Link](https://x.com/tenet_research/status/1942675525052387812)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

tenet_research Avatar TENET RESEARCH @tenet_research on x 452.8K followers Created: 2025-07-08 20:01:52 UTC

$RYTM - Rhythm Pharmaceuticals To Announce Topline Results from Phase X Trial Evaluating Oral MC4R Agonist Bivamelagon in Acquired Hypothalamic Obesity

XXXXX engagements

Engagements Line Chart

Related Topics $rytm

Post Link

post/tweet::1942675525052387812
/post/tweet::1942675525052387812